Last Updated on November 16, 2024 by The Health Master
Supplements
The supplements industry is set to face tighter regulations as the government takes steps to curb misleading health claims.
A government panel has recommended shifting the oversight of supplements with exaggerated health claims from the Food Safety and Standards Authority of India (FSSAI) to the Central Drugs Standard Control Organisation (CDSCO).
Why the Change?
The move aims to address the growing concern over supplements that make unsubstantiated claims of curing or preventing diseases.
By bringing these products under the purview of the CDSCO, the government intends to ensure stricter scrutiny and accountability.
Key Recommendations of the Expert Panel:
- Stricter Regulation for Disease Claims: The panel has proposed that claims related to curing, mitigating, or reducing the risk of diseases should be regulated by the CDSCO.
- FSSAI to Focus on Nutritional Claims: The FSSAI will continue to regulate nutritional and health claims that are already listed under the FSS (Claims and Advertisements) Regulations 2018.
- Mandatory Label Submission: The panel has recommended that manufacturers submit product labels along with health claims at the time of licensing.
The Need for a Unified Regulatory Framework
The rapid growth of the nutraceutical industry has led to a surge in products with misleading claims.
To address this issue, a high-level committee has been formed to review existing guidelines and develop a comprehensive regulatory framework.
This committee includes representatives from various government agencies, including the Ministry of Health and Family Welfare, the Ministry of Food Processing Industries, and the Department of Pharmaceuticals.
In conclusion, as the government takes steps to strengthen the regulation of supplements, consumers can expect to see more accurate and truthful labeling.
This move will not only protect public health but also ensure fair competition in the industry.
Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
The Future of Health Supplements: New Stricter Regulations
Recommendations for New Rules for Nutraceuticals: FSSAI
CDSCO to implement stricter regulations for health supplements
Nutraceutical Industry seeks separate Regulatory Agency
Govt Considers Price Control on Nutraceuticals in India
Nutraceutical Manufacturing in Drug Facilities: 5 members committee formed
India emerges as a Global Nutraceutical Powerhouse
Nutraceuticals in Drug Units: Panel to examine the issue
FOPE: Impact of revised Schedule M on Pharma and Nutraceuticals
Exploring Regulatory Shifts: Nutraceuticals and the Role of CDSCO
Indian Pharma Industry’s journey into Nutraceuticals
Nutraceuticals in India: A step towards empowering Pharma Industry
Nutraceutical Industry: Opportunities and Measures for India
Nutraceutical industry trends will rule the year
IPA calls Nutraceutical, Pharma industries to join hands to provide holistic care
Nutraceuticals Regulations 2022 to encourage Pharma Industry
Nutraceuticals: India can become a Global Leader
Nutraceuticals: A strong Regulation is needed
Bring Nutraceuticals for prevention of diseases under DCGI’s regulation: Experts to Govt
Nutraceuticals for mental well-being
Nutraceuticals: From Alternative to Mainstream
Nutraceuticals in India: A game changing opportunity
Indian Nutraceutical industry now a days
Nutraceutical Industry: A trending Market
PLI scheme: Boost for the growth of the Nutraceutical sector
Nutraceutical Industry seeks separate Regulatory Agency
Govt Considers Price Control on Nutraceuticals in India
Telangana DCA Uncover Illegally Manufactured “Nutraceuticals”
Nutraceutical Manufacturing in Drug Facilities: 5 members committee formed
India emerges as a Global Nutraceutical Powerhouse
Nutraceuticals in Drug Units: Panel to examine the issue
Important short notes for Industry
Govt upholds ceiling price fixation for Azathioprine 50 mg
CDSCO Nod granted to Conduct Clinical Trial of Ruxolitinib cream
No provision for separate license for Pharma marketers
Important short notes for Industry
Deadly reactor explosion at Pharma Plant in Andhra Pradesh
Drug recall: Dr Reddy’s recalls Cinacalcet Tablets due to impurity Concerns
Indian Pharma Industry to face New GMP Regulations Compliance
Clotrimazole Cream Price Dispute: Govt upholds NPPA’s Ceiling Price
Telangana DCA takes action on 15 Medical Stores for Violations
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
